Sponsor or institution

Clinical trials and research at PETHEMA Foundation

• 7Clinical trials
• 2Countries

Newest trials

All recruiting trials (7)

• Oral Decitabine plus Ivosidenib as first-line treatment for older or unfit adults with AML

  This study tests whether combining oral decitabine with ivosidenib can help older or unfit adults with AML that has an IDH1 mutation to reach remission.

  Recruiting at 6 sites Phase 2 PETHEMA Foundation · Aveiro and 19 other locations · NCT07507760

• Venetoclax and Azacitidine with or without Quizartinib in older/unfit adults with AML

  This trial tests whether adding Quizartinib to Venetoclax and Azacitidine helps older or unfit adults with AML live longer compared with the standard Venetoclax and Azacitidine therapy.

  Recruiting at 24 sites Phase 3 PETHEMA Foundation · Santiago de Compostela, A Coruña and 51 other locations · NCT07478991

• Anitocabtagene autoleucel after four‑drug induction for newly diagnosed multiple myeloma

  This tests whether a single infusion of anitocabtagene autoleucel given after a four‑drug induction helps adults with newly diagnosed multiple myeloma achieve deeper remissions and undetectable minimal residual disease.

  Recruiting at 10 sites Phase 2 PETHEMA Foundation · Badalona and 9 other locations · NCT07045909

• Ciltacabtagene autoleucel treatment for high-risk smoldering multiple myeloma

  This study is testing a new CAR-T therapy called cilta-cel to see if it can help people with high-risk smoldering multiple myeloma achieve better treatment results and stay healthy.

  Recruiting Phase 2 PETHEMA Foundation · Salamanca · NCT06574126

• Combining zanubrutinib and obinutuzumab for untreated chronic lymphocytic leukemia or small lymphocytic lymphoma

  This study is testing if combining two medications, zanubrutinib and obinutuzumab, can help people with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma achieve better treatment results.

  Recruiting at 19 sites Phase 2 PETHEMA Foundation · Alicante and 18 other locations · NCT06544785

• Extended VRD plus vs Isa-VRD vs Isa-V-Iberdomide as part of ASCT in newly diagnosed multiple myeloma

  This trial tests three treatment approaches added to autologous stem cell transplant to see which best clears disease in newly diagnosed myeloma.

  Recruiting at 65 sites Phase 3 PETHEMA Foundation · Alcalá de Henares, Madrid and 67 other locations · NCT05558319

• Treatment for adults with a specific type of leukemia

  This study is testing a new treatment plan for adults with a specific type of leukemia to see if it helps them stay healthy after their initial therapy.

  Recruiting at 23 sites PETHEMA Foundation · Badalona, Barcelona and 107 other locations · NCT04179929

Quick answers

How many clinical trials run by PETHEMA Foundation are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Spain (7 trials), Portugal (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →